Darla Liles

Fox Chase Cancer Center — United States

Medicine · Health Sciences

20h-index2.5kcitations151works5.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemoglobinopathies and Related Disorders(48), Iron Metabolism and Disorders(35), Platelet Disorders and Treatments(15), Complement system in diseases(13), Hemophilia Treatment and Research(11)

Publications151 total

Targeting chemoresistance: A phase II study of iadademstat (Iada) with paclitaxel (P) in extrapulmonary neuroendocrine carcinoma (epNEC) and small cell lung cancer (SCLC).
Journal of Clinical Oncology·2026
Evaluating the feasibility and acceptability of study procedures for a full factorial trial of ASCENT: protocol for a randomized pilot
Pilot and Feasibility Studies·2025Open Access
Risk Factors for COVID-19–Related Hospitalization and Death in Patients With Cancer
JAMA Oncology·2025· 3 citedOpen Access
Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes
Nature Genetics·2025Open Access
Race, rituximab, and relapse in TTP
UNC Libraries·2025Open Access
Acute myeloid leukemia mitochondria hydrolyze ATP to support oxidative metabolism and resist chemotherapy
Science Advances·2025· 12 citedOpen Access
Safety profile of crizanlizumab 5.0 mg/kg in sickle cell disease: pooled data from clinical trials
Journal of sickle cell disease.·2025Open Access
Relapse Free Survival Progressive Shortens in a Subset of Black patients with Immune TTP Treated in the Rituximab Era
UNC Libraries·2024Open Access
Diffuse Large B-Cell Lymphoma Presenting Primarily as a Cutaneous Leg Lesion: A Case Report and Literature Review
Cureus·2024Open Access
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era
Blood Advances·2024· 2 citedOpen Access
Comparative Outcomes of Acute Gallstone Disease in Patients with and without Sickle Cell Disease: A Retrospective Cohort Study Using the National Inpatient Sample
Blood·2024
Identification and Characterization of Primary Factor VII Gene Mutations and Incidentally Detected Secondary MTHFR and ITGA2 Genetic Variants in a Factor VII Deficiency Cohort: A Single-Hemophilia Center Study
Blood·2024Open Access
CD38-SADA Pretargeted Radioimmunotherapy (PRIT) with Lutetium 177 (Lu177)-DOTA in Adult Patients with Relapsed or Refractory Non-Hodgkin Lymphoma: A First-in-Human Phase 1 Trial
Blood·2024Open Access
The use of abstract animations and a graphical body image for assessing pain outcomes among adults with sickle cell disease
Journal of Pain·2024· 1 citedOpen Access
Digital cognitive behavioral therapy vs education for pain in adults with sickle cell disease
Blood Advances·2024· 12 citedOpen Access
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura
UNC Libraries·2024Open Access
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes
Nature Genetics·2024· 58 citedOpen Access
NRG Oncology/RTOG 0848: Results after adjuvant chemotherapy +/- chemoradiation for patients with resected periampullary pancreatic adenocarcinoma (PA).
Journal of Clinical Oncology·2024· 20 cited
Voxelotor for Sickle Cell Disease: Initial Report from the Real-world PROSPECT Study
Journal of sickle cell disease.·2024· 1 citedOpen Access
Acute myeloid leukemia mitochondria hydrolyze ATP to resist chemotherapy
2024· 2 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Julie Kanter(6), Abdullah Kutlar(5), Kenneth I. Ataga(4), Victor R. Gordeuk(4), Charles Knupp(4), Mahvish Muzaffar(4), Paul R. Walker(4), Dougald M. Monroe(4), Harold R. Roberts(4), Rodolfo Delfini Cançado(3), João Ricardo Friedrisch(3), Jennifer Knight‐Madden(3), Ofelia Álvarez(3), Wally R. Smith(3), Sundar Jagannath(3), Ravi Vij(3), Gregory Orloff(3), Rubén Niesvizky(3), Jeffrey L. Wolf(3), Austin Christofferson(3)